A Randomized Phase II Trial of Atezolizumab With or Without Bevacizumab in Cisplatin-ineligible Patients With Advanced/Unresectable Urothelial Cancer
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2018
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 06 Jun 2018 Planned End Date changed from 1 May 2019 to 1 Jan 2019.
- 06 Jun 2018 Planned primary completion date changed from 1 May 2018 to 1 Jan 2019.
- 11 Oct 2017 Status changed from not yet recruiting to recruiting.